622-36-6

Basic information

• Product Name: Hydrazine, 1-methyl-2-phenyl-
• CAS NO: 622-36-6
• Molecular Formula: C7H10N2
• Molecular Weight: 122.17
• Mol File: 622-36-6.mol

Chemical Properties

• CAS DataBase Reference: Hydrazine, 1-methyl-2-phenyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Hydrazine, 1-methyl-2-phenyl-(622-36-6)
• EPA Substance Registry System: Hydrazine, 1-methyl-2-phenyl-(622-36-6)

Safety Data

• Hazardous Substances Data: 622-36-6(Hazardous Substances Data)

Upstream product

• 60-80-0 antipyrine 
• 519-65-3 Dimethylaminooxoessigsaeure-2-acetyl-2-methyl-1-phenylhydrazid 
• 102311-46-6 N,N'-dibenzoyl-N-methyl-N'-phenyl-hydrazine 
• 37046-82-5 1,4-diphenylhexahydro-1,2,4,5-tetrazine 
• 50-00-0 formaldehyd 
• 100-63-0 phenylhydrazine 
• 622-84-4 2-formyl-1-phenylhydrazine 
• 6228-40-6 formaldehyde phenylhydrazone 
• 129502-46-1 C₂₅H₂₄N₂P⁽¹⁺⁾*I^(1-) 
• 885-11-0 1,5-dimethyl-4-nitroso-2-phenyl-1,2-dihydro-pyrazol-3-one 
• 74-88-4 methyl iodide 
• 74-83-9 methyl bromide 
• 77-78-1 dimethyl sulfate 
• 64-17-5 ethanol 

Downstream Products

• 740845-82-3 4-(2-hydroxy-ethyl)-1,5-dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one 
• 50877-87-7 1,3-dimethyl-2-phenylpyrazol-5-one 
• 30769-69-8 N,N-dimethyl-N'-phenylhydrazine 
• 858843-30-8 phenyl-thioacetic acid-(N-methyl-N'-phenyl-hydrazide) 
• 110146-24-2 2-methyl-3-oxo-1,5-diphenyl-2,3-dihydro-1H-pyrazole-4-carboxylic acid ethyl ester 
• 97141-44-1 2-methyl-1,4-diphenyl semicarbazide 
• 66202-78-6 2-methyl-1,4-diphenyl thiosemicarbazide 
• 25874-88-8 N-ethyl-N'-methyl-N-phenyl-hydrazine 
• 38604-70-5 1-acetyl-1-methyl-2-phenylhydrazine 
• 99673-78-6 4-(2-diethylamino-ethyl)-1,5-dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one 
• 723-74-0 1-methyl-2-phenyl-5-trifluoromethyl-1,2-dihydro-3H-pyrazol-3-one 
• 104439-88-5 5-ethyl-2-methyl-1-phenyl-1,2-dihydro-pyrazol-3-one 
• 21075-66-1 4-tert.-Butyl-2-methyl-1-phenyl-thiosemicarbazid 
• 7115-77-7 N-Cyan-N-phenyl-N'-methyl-hydrazin 

Relevant articles and documents

6-Heteroarylpyridoindolone Derivatives, Their Preparation and Therapeutic Use Thereof

The disclosure relates to compounds of formula (I): wherein R1, R2, R3, R4, are R5 are as defined in the disclosure; their preparation method, compositions containing the same and therapeutic use thereof.

Piperazine derivatives as therapeutic agents

Substituted piperazine compounds of formula I STR1 in which HET is a substituted pyrazole, imidazole or 1,2,4-triazole have utility in the treatment of central nervous system disorders, for example depression, anxiety, psychoses (for example schizophrenia), tardive dyskinesia, Parkinson's disease, obesity, hypertension, Tourette's syndrome, sexual dysfunction, drug addiction, drug abuse, cognitive disorders, Alzheimer's disease, senile dementia, obsessive-compulsive behaviour, panic attacks, social phobias, eating disorders and anorexia, cardiovascular and cerebrovascular disorders, non-insulin dependent diabetes mellitus, hyperglycaemia, constipation, arrhythmia, disorders of the neuroendocrine system, stress, prostatic hypertrophy, and spasticity.

Regioselective Synthesis of 1-Alkyl-1-phenylhydrazines, 2-Alkyl-1-phenylhydrazines, and 1,2-Dialkyl-1-phenylhydrazines

1,2- and 1,1-disubstituted and 1,1,2-trisubstituted hydrazines are obtained by reaction of (2-phenylhydrazino)triphenylphosphonium bromide with butyllithium, followed by addition of alkyl halides and alkaline hydrolysis.